Efficacy, Tolerability and Safety of Early Introduction of Everolimus, Reduced Calcineurin Inhibitors and Early Steroid Elimination Compared to Standard CNI, Mycophenolate Mofetil and Steroid Regimen in Paediatric Renal Transplant Recipients
Clinical trial NCT01544491 · COMPLETED
Trial details
- NCT number
- NCT01544491
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-17
- Primary completion
- 2016-10-03
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.